Praxsyn Corporation (PXYN) Financial Statements (2023 and earlier)

Company Profile

Business Address 1803 SKY PARK CIRCLE
IRVINE, CA 92614
State of Incorp. IL
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,222182
Cash and cash equivalents1,222182
Receivables8,561  
Inventory, net of allowances, customer advances and progress billings202
Inventory202  
Prepaid expense 0
Prepaid expense and other current assets2
Other current assets16 
Other undisclosed current assets1,573  
Total current assets:11,574283
Noncurrent Assets
Property, plant and equipment801152
Long-term investments and receivables4,140  
Accounts and financing receivable, after allowance for credit loss4,140  
Other noncurrent assets8 
Deferred tax assets, net903  
Total noncurrent assets:5,1301152
TOTAL ASSETS:16,70413136
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:9,1112,1401,597
Settlement liabilities70
Interest and dividends payable1,573  
Accounts payable483  
Accrued liabilities6,984  
Other undisclosed accounts payable and accrued liabilities 2,1401,597
Debt(3,876)587655
Derivative instruments and hedges, liabilities  248
Disposal group, including discontinued operation962  
Deferred revenue and credits122  
Due to related parties199  
Other undisclosed current liabilities8,3281,358617
Total current liabilities:14,8454,0853,118
Noncurrent Liabilities
Long-term debt and lease obligation227  
Long-term debt, excluding current maturities227  
Liabilities, other than long-term debt377  
Accounts payable and accrued liabilities377  
Other undisclosed noncurrent liabilities(377) 248
Total noncurrent liabilities:227 248
Total liabilities:15,0724,0853,366
Equity
Equity, attributable to parent1,632(4,072)(3,230)
Treasury stock, value(200)  
Additional paid in capital54,24016,16211,567
Accumulated deficit(52,408)(20,234)(14,797)
Total equity:1,632(4,072)(3,230)
TOTAL LIABILITIES AND EQUITY:16,70413136

Income Statement (P&L) ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
66,599  
Cost of revenue(3,586)  
Gross profit:63,013  
Operating expenses(36,947)(988)(2,825)
Other undisclosed operating income  1,088
Operating income (loss):26,066(988)(1,737)
Nonoperating income (expense)(38,635)(4,448)859
Investment income, nonoperating 122,742
Interest and debt expense(458)(223) 
Other undisclosed income from continuing operations before equity method investments, income taxes458223 
Loss from continuing operations before income taxes:(12,568)(5,436)(878)
Income tax expense (benefit)214(1)(2)
Loss from continuing operations:(12,354)(5,437)(879)
Loss before gain (loss) on sale of properties:(12,354)(5,437)(879)
Net loss:(12,354)(5,437)(879)
Other undisclosed net loss attributable to parent  (340)
Net loss attributable to parent:(12,354)(5,437)(1,219)
Other undisclosed net income available to common stockholders, basic  322
Net loss available to common stockholders, diluted:(12,354)(5,437)(897)

Comprehensive Income ($ in thousands)

12/31/2014
12/31/2013
12/31/2012
Net loss:(12,354)(5,437)(879)
Comprehensive loss, net of tax, attributable to parent:(12,354)(5,437)(879)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: